Table III.
FINS (mIU/L), HOMA-IR and AUC in all groups.
| Group | n | FINS (mIU/l) | HOMA-IR | AUC |
|---|---|---|---|---|
| NC | 10 | 7.51±2.60 | 2.68±0.98 | 23.25±1.68 |
| DC | 8 | 8.37±2.31 | 6.56±2.80a | 53.56±5.76a |
| S1P | 9 | 8.39±1.93 | 5.82±1.44a | 51.70±6.45a |
Values are expressed as the mean ± standard deviation. Parametric one-way analysis of variance followed by Least Significant Difference post hoc test was performed for the comparison of the groups.
a
P<0.01 vs. NC. NC, normal control; DC, diabetic control; S1P, sphingosine-1-phosphate; FINS, fasting insulin; HOMA-IR, homeostatic model assessment of insulin resistance; AUC, areas under the curve.